
Prevail Therapeutics
Prevail Therapeutics develops adeno-associated virus gene therapies for patients with neurodegenerative diseases.
- 15
- Acquired, subsidiary of Eli Lilly and Company
- New York City, NY, USUnited States
Prevail Therapeutics develops adeno-associated virus gene therapies to treat neurodegenerative diseases including Parkinson disease, Gaucher disease, and dementia. The biotechnology platform designs therapeutic vectors to restore lysosomal function and address genetic drivers of neurodegeneration.
Eli Lilly and Company acquired Prevail Therapeutics to establish a dedicated gene therapy research center and expand its neuroscience drug pipeline. Prevail continues active operations as a wholly owned subsidiary advancing clinical development programs.
Similar Companies

Lacerta Therapeutics

Lysosomal Therapeutics
lysosomaltx.com

Affinia Therapeutics
affiniatx.com

Denali Therapeutics

Arkuda Therapeutics
arkudatx.com

Aavogen
aavogen.com
Endlyz Therapeutics
endlyz.com

Voyager Therapeutics

Greenland Mines
anewmeds.com

Apertura Gene Therapy
aperturagtx.com

Poseida Therapeutics
poseida.com

nVector
nvector.com

Dyno Therapeutics
dynotx.com

Aztherapies

Neurogene
neurogene.com

Chameleon Biosciences

ADvantage Therapeutics

Libra Therapeutics

Verve Therapeutics
vervetx.com

Gain Therapeutics
Quick Facts
Who are Prevail Therapeutics' competitors?
Companies similar to Prevail Therapeutics include Lacerta Therapeutics, Lysosomal Therapeutics, Affinia Therapeutics and Denali Therapeutics.
When was Prevail Therapeutics founded?
Prevail Therapeutics was founded in 2017.
Where is Prevail Therapeutics' headquarters located?
Prevail Therapeutics' headquarters is located in New York City, NY, US.
How much disclosed funding has Prevail Therapeutics raised?
As of Jan 22, 2021, Prevail Therapeutics has disclosed funding of $129M (USD). Undisclosed round amounts are excluded.
How many employees does Prevail Therapeutics have?
Prevail Therapeutics has 15 employees as of Oct 1, 2026.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2836Biological Products, Except Diagnostic Substances
- 2800Chemicals And Allied Products
- 2830Drugs
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325414Biological Product (except Diagnostic) Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research